CN Patent

CN110891561A — 治疗痤疮的方法和组合物

Assigned to Shenzhen Beimei Pharmaceutical Co Ltd · Expires 2020-03-17 · 6y expired

What this patent protects

本申请涉及在患有痤疮的受试者中治疗痤疮的方案、治疗方法和组合物。

USPTO Abstract

本申请涉及在患有痤疮的受试者中治疗痤疮的方案、治疗方法和组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN110891561A
Jurisdiction
CN
Classification
—
Expires
2020-03-17
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Beimei Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.